DOCS vs VRSN
Doximity, Inc. and Verisign Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DOCS | VRSN |
|---|---|---|
| Revenue | $644.9M | $1.7B |
| Net income | $196.1M | $825.7M |
| Gross margin | 89.1% | 88.2% |
| Net margin | 30.4% | 49.8% |
| Return on equity | 19.3% | · |
| Diluted EPS | $0.98 | · |
| Dividend / share | · | $2.31 |
| Payout ratio | · | 26.1% |
| Free cash flow | $326.5M | $1.1B |
| Equity | $950.8M | $-2.2B |
| Net debt / equity | · | · |
| Current ratio | 6.09× | 0.49× |
| Revenue CAGR 5y | 25.5% | 5.5% |
| Profit CAGR 5y | 31.3% | 0.3% |
VRSN bills 2.6× the revenue of DOCS, and keeps more of each dollar of revenue as profit (49.8% against 30.4%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | DOCS | VRSN |
|---|---|---|
| FY2025 | $644.9M | $1.7B |
| FY2024 | $570.4M | $1.6B |
| FY2023 | $475.4M | $1.5B |
| FY2022 | $419.1M | $1.4B |
| FY2021 | $343.5M | $1.3B |
| FY2020 | $206.9M | $1.3B |
| FY2019 | $116.4M | $1.2B |
Bottom line
| Fiscal year | DOCS | VRSN |
|---|---|---|
| FY2025 | $196.1M | $825.7M |
| FY2024 | $223.2M | $785.7M |
| FY2023 | $147.6M | $817.6M |
| FY2022 | $112.8M | $673.8M |
| FY2021 | $154.8M | $784.8M |
| FY2020 | $50.2M | $814.9M |
| FY2019 | $29.7M | $612.3M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$1,011,737,000 | VRSN |
| FY2024 | −$987,001,000 | VRSN |
| FY2023 | −$1,017,678,000 | VRSN |
| FY2022 | −$1,005,848,000 | VRSN |
| FY2021 | −$984,052,000 | VRSN |
| FY2020 | −$1,058,203,000 | VRSN |
| FY2019 | −$1,115,273,000 | VRSN |
VRSN has reported the higher revenue in every one of these 7 fiscal years. The gap has narrowed since the earliest year compared.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −19.4 pp | VRSN |
| FY2024 | −11.3 pp | VRSN |
| FY2023 | −23.7 pp | VRSN |
| FY2022 | −20.4 pp | VRSN |
| FY2021 | −14.1 pp | VRSN |
| FY2020 | −40.1 pp | VRSN |
| FY2019 | −24.2 pp | VRSN |
VRSN has kept the higher net margin in every one of these 7 fiscal years.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DOCS's net margin has been more volatile than VRSN's over the 7 comparable fiscal years — 7.1 percentage points of standard deviation against 5.7.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
VRSN led in net margin in every one of the 7 comparable fiscal years — a structural lead, not a recent swing.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.